Search results
Results from the WOW.Com Content Network
Shift Up Corporation (stylized in all caps; Korean: 시프트업) is a South Korean video game developer and publisher. It was founded on December 2, 2013, by Kim Hyung Tae and is best known for the games Goddess of Victory: Nikke and Stellar Blade .
Goddess of Victory: Nikke [a] is a third-person shooter action role-playing video game developed by South Korean developer Shift Up and published by Level Infinite.Development of Nikke began as early as 2017, and it was released for Android and iOS in 2022, and Windows in 2023.
Stellar Blade (Korean: 스텔라 블레이드) is a 2024 action-adventure game developed by Shift Up and published by Sony Interactive Entertainment.Players take control of the protagonist, Eve, as she embarks on a mission to save humanity from a relentless war against monstrous creatures in a distant future.
Shift Up said nothing had been decided on pricing yet, with it to be determined after the bookbuilding process ended. If finalised, the pricing would give the game developer a market ...
Eve (Korean: 이브, romanized: Ibeu), stylized as EVE, is a character introduced in and the protagonist of the 2024 video game Stellar Blade by developer Shift Up, and created by Kim Hyung Tae. Eve is a soldier sent from a space station called the Colony to help save mankind, who are fighting against creatures called Naytiba that have overrun ...
Pages in category "Shift Up games" The following 3 pages are in this category, out of 3 total. ... Developers; Statistics; Cookie statement; Mobile view; Search. Search.
The fox with a stick equipped and health and stamina meters in the bottom left. An enemy is chasing the fox, and a shrine is nearby. Tunic is an action-adventure game set in the ruins of a post-apocalyptic fantasy world, in which the player character, an anthropomorphic fox, navigates the terrain and fights off hostile creatures.
The biggest development in weight-loss medicine since bariatric surgery (not to mention less invasive), the medications, which were initially approved to treat type 2 diabetes, have exploded in ...